Q: Your report on GUD indicated a very favourable view of the company. I would appreciate your thoughts on the possibility/likelihood of the very smart and very patient Mr. Goodman taking advantage of the recent slaughter among many of the small cap specialty pharma companies. Is this when that large cash balance starts to be deployed?
Thanks.
Thanks.